These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1945177)

  • 1. The economics of serum cholesterol reduction.
    Amarasingham R
    N Z Med J; 1991 Nov; 104(923):477-9. PubMed ID: 1945177
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs and health consequences of cholesterol screening for asymptomatic older Americans.
    Garber AM; Littenberg B; Sox HC; Wagner JL; Gluck M
    Arch Intern Med; 1991 Jun; 151(6):1089-95. PubMed ID: 1904212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.
    Hamilton VH; Racicot FE; Zowall H; Coupal L; Grover SA
    JAMA; 1995 Apr; 273(13):1032-8. PubMed ID: 7897787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valuing prevention: discounting health benefits and costs in New Zealand.
    Milne R
    N Z Med J; 2005 May; 118(1214):U1443. PubMed ID: 15886738
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the importance of various diseases on mortality].
    Kjeldsen K
    Ugeskr Laeger; 1974 Oct; 136(41):2313-8. PubMed ID: 4217001
    [No Abstract]   [Full Text] [Related]  

  • 6. Cigarette smoking and lifetime medical expenditures.
    Hodgson TA
    Milbank Q; 1992; 70(1):81-125. PubMed ID: 1588892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are low-cholesterol diets expensive?
    Scott LW; Foreyt JP; Young J; Reeves RS; O'Malley MP; Gotto AM
    J Am Diet Assoc; 1979 May; 74(5):558-61. PubMed ID: 438452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand.
    Moore PV; Bennett K; Normand C
    Appl Health Econ Health Policy; 2014 Dec; 12(6):623-33. PubMed ID: 25141830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol, children, and heart disease: an analysis of alternatives.
    Berwick DM; Cretin S; Keeler E
    Pediatrics; 1981 Nov; 68(5):721-30. PubMed ID: 6796932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic costs of drug abuse.
    Rice DP; Kelman S; Miller LS
    NIDA Res Monogr; 1991; 113():10-32. PubMed ID: 1762634
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale of the diet-heart statement of the American Heart Association. Report of the AHA nutrition committee.
    Arteriosclerosis; 1982; 2(2):177-91. PubMed ID: 7039581
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
    Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
    N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to lower cholesterol.
    Shaw P
    Med J Aust; 1988 Oct; 149(8):450, 452. PubMed ID: 3173215
    [No Abstract]   [Full Text] [Related]  

  • 14. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure.
    Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Wilson N
    N Z Med J; 2014 May; 127(1393):12-25. PubMed ID: 24816953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart healthy education. Effectiveness of teaching methods in the workplace.
    Reed G; Moore L; Coleman L
    AAOHN J; 1991 Mar; 39(3):109-13. PubMed ID: 2001271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet, serum cholesterol and the prevention of coronary heart disease in New Zealand.
    Beaglehole R; Jackson R; Stewart A
    N Z Med J; 1988 Jun; 101(848):415-8. PubMed ID: 3393329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive cardiology--and what then?].
    Werkö L
    Lakartidningen; 1970 Sep; 67(37):4136-7 passim. PubMed ID: 5474909
    [No Abstract]   [Full Text] [Related]  

  • 19. Maximum and optimum in health services.
    Cohen J
    Isr J Med Sci; 1974; 10(1):116-27. PubMed ID: 4207646
    [No Abstract]   [Full Text] [Related]  

  • 20. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.